Oral Squamous Cell CarcinomaSymptoms, Doctors, Treatments, Advances & More
Oral Squamous Cell Carcinoma Overview
Learn About Oral Squamous Cell Carcinoma
Appalachian Radiation Oncology Associates PC
. Dr. Colvett is rated as a Distinguished provider by MediFind in the treatment of Oral Squamous Cell Carcinoma. His top areas of expertise are Oral Squamous Cell Carcinoma, Laryngeal Cancer, Pleuropulmonary Blastoma, and Lung Cancer.
Ear Nose And Throat Associates, PC
. Dr. Zajonc is rated as a Distinguished provider by MediFind in the treatment of Oral Squamous Cell Carcinoma. His top areas of expertise are Oral Squamous Cell Carcinoma, Low Nasal Bridge, Nasal Septal Hematoma, Perichondritis, and Myringotomy.
Cancer Centers Of Colorado - St. Mary's Regional Hospital (Med Onc)
Dr. Kyle Work joined the Cancer Centers of Colorado at St. Mary?s Medical Center oncology team in 2018. He is a hematologist-oncologist. Dr. Work treats all types of cancers with a special interest in head and neck cancer, lung cancer and genitourinary cancers.Dr. Work is originally from Tulsa, Oklahoma where he graduated from the University of Tulsa with a degree in biology, and earned his medical degree at Oklahoma State University. He then moved to Kansas City where he completed his internal medicine residency and hematology / oncology fellowship at the University of Kansas Health System. During his hematology and oncology fellowship, he served as chief fellow for two years.Dr. Work is an investigator involved in clinical research trials in the area of hematology and medical oncology. His clinical research focus includes head and neck cancers, brain and lung cancers. When he is not working, he enjoys mountain biking, camping, and hiking with his wife and golden retrievers. Dr. Work is rated as an Advanced provider by MediFind in the treatment of Oral Squamous Cell Carcinoma. His top areas of expertise are Lung Cancer, Pleuropulmonary Blastoma, EGFR Positive Lung Cancer, and Squamous Cell Lung Carcinoma.
Summary: This is a multicenter, open-label, randomized phase III clinical trial evaluating perioperative treatment with sintilimab combined with chemotherapy in patients with locally advanced oral squamous cell carcinoma. Despite standard treatment with surgery followed by postoperative radiotherapy or chemoradiotherapy, patients with locally advanced oral squamous cell carcinoma remain at high risk of rec...
Summary: Investigating the Relationship Between Oral Microbiome Alterations and Tumor Markers in Locally Advanced Oral Squamous Cell Carcinoma (LA-OSCC) After Neoadjuvant Chemoimmunotherapy: Implications for Therapeutic Efficacy, Chemoresistance, and Prognostic Assessment


